Trial Search Results
Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer
The purpose of this study is to determine if Indocyanine Green (IC-GREEN) is comparable to isosulfan blue (IS-BLUE) in the identification of arm lymphatics and arm-draining nodes during nodal staging procedures in breast cancer.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: SPY Elite Imaging
- Drug: Indocyanine Green
- Drug: Isosulfan blue
- Drug: 99technetium-sulfur colloid radiolabel
Phase:
Phase 2
Eligibility
Inclusion Criteria:
- Ability to understand and the willingness to sign a written informed consent document.
- Signed written informed consent.
- Women undergoing sentinel lymph node biopsy.
- Women with breast cancer with known or suspected lymph node involvement.
- Women undergoing sentinel node identification and completion axillary lymph node
dissection.
- Women of 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2.
- Complete Blood Count (CBC) and basic Metabolic Panel within 6 months
Exclusion Criteria:
- History of liver or kidney failure will not be eligible.
- Allergies to iodine containing products will not be eligible.
- Women who are pregnant will not be eligible.
- Psychiatric or addictive disorders or other conditions that, in the opinion of the
investigator, would preclude the patient from meeting the study requirements.
Ages Eligible for Study
18 Years - 90 Years
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Shannon Meyer
650-724-1953